Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE

Yahoo FinanceMar 27 20:53

CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders

Yahoo FinanceMar 19 18:30

Takeda Pharmaceutical GAAP EPS of ¥94.00, Revenue of ¥3212.9B; Reaffirms FY23 Guidance

Seeking AlphaFeb 1 14:21

Cognizant Helping to Modernize Infrastructure and Application Management as Part of Takeda's Digital Transformation

Yahoo FinanceJan 26 06:00

ImmunoGen Inks Deal With Takeda for Cancer Drug Elahere

Seeking AlphaAug 28, 2023 19:12

Takeda Moves Out From Licensing Agreement With Theravance Biopharma

In its Q1 earnings release, Takeda Pharmaceutical Co Ltd (NYSE:TAK) said it agreed to discontinue further development of TAK-954 for post-operative gastrointestinal dysfunction and the parties' collab

BenzingaMay 12, 2023 01:41